Clinical Trial Details

EORTC-62962

Back to Clinical Trials Database

Phase II Study of Caelyx (Doxorubicin HCl, pegylated liposomal) or Doxorubicin in previously untreated adult patients with advanced and/or metastatic soft tissue sarcomas.

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 06-May-1997
Date Step1 close: 30-Jun-1998
Data management at EORTC Yes
Design Phase 2
Randomized open label
Targeted Sample size EORTC Groups: 80
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/
NCT number